A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight

NCT07004322 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Obesity

Interventions

DRUG: NNC0519-0130
DRUG: Placebo

Sponsor

Novo Nordisk A/S